Ahram Biosystems
PrivateLast Round
M&A
May 14, 2020
Total Funding Raised
$11.57M
Company Overview
Ahram Biosystems operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Grant round in October 2017.
Ahram Biosystems is a diagnostic equipment company that develops life science tools designed to bring portable technology to the biotechnology market, including PCR devices and cell-based assay systems.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ahram Biosystems Comparables
Compare Ahram Biosystems with similar companies based on industry and business-model similarity.
No comparables are published for Ahram Biosystems. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Ahram Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 14, 2020 | ||||
| Grant | Oct 16, 2017 | ||||
| Series B | Mar 9, 2017 | ||||
| Grant | Nov 11, 2015 | ||||
| Early Funding | Mar 24, 2015 |
For institutional investors. Book with your work email.
Ahram Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Early Funding |
| CJ Investment | Series B |
| Korea Institute for Advancement of Technology | Grant |
| Daol Investment | Series B |
| Ministry of Trade, Industry and Energy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 35% MoM, reaching 2.1K.
- Jan 23, 2026
Monthly visitors grew 67% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Ahram Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ahram Biosystems's valuation, stock price, and market status.
Is Ahram Biosystems a public or private company?
Ahram Biosystems is a private company.
What is the current stock price of Ahram Biosystems?
Ahram Biosystems is a private company, so its shares have no public market price. Caplight tracks Ahram Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ahram Biosystems worth (valuation)?
Valuation information for Ahram Biosystems is not publicly available.
Can I buy Ahram Biosystems stock?
Ahram Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ahram Biosystems's last funding round?
Ahram Biosystems's most recent funding round was M&A on May 14, 2020.
Who are the main investors in Ahram Biosystems?
Key investors in Ahram Biosystems include SV Investment, CJ Investment, Korea Institute for Advancement of Technology, Daol Investment, Ministry of Trade, Industry and Energy.
Will Ahram Biosystems IPO soon?
No public IPO plans have been announced for Ahram Biosystems.
How can I track Ahram Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Ahram Biosystems's shares on secondary markets.